Trupanion (NASDAQ:TRUP) PT Lowered to $34.00

Trupanion (NASDAQ:TRUPFree Report) had its price objective cut by Canaccord Genuity Group from $40.00 to $34.00 in a research report sent to investors on Friday morning, Benzinga reports. They currently have a buy rating on the financial services provider’s stock.

A number of other analysts have also issued reports on the stock. Evercore ISI dropped their price target on shares of Trupanion from $35.00 to $31.00 and set an outperform rating for the company in a research note on Tuesday, February 20th. Stifel Nicolaus upped their target price on shares of Trupanion from $25.00 to $28.00 and gave the company a hold rating in a research note on Friday, February 16th. Finally, Piper Sandler decreased their price target on Trupanion from $28.00 to $22.00 and set a neutral rating for the company in a research note on Friday. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of Hold and an average price target of $29.40.

Read Our Latest Stock Report on Trupanion

Trupanion Trading Up 13.4 %

NASDAQ TRUP opened at $22.51 on Friday. The company’s fifty day simple moving average is $25.58 and its 200-day simple moving average is $26.70. Trupanion has a 52 week low of $18.45 and a 52 week high of $36.66. The company has a current ratio of 1.62, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The stock has a market cap of $945.19 million, a P/E ratio of -35.17 and a beta of 1.76.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.02. Trupanion had a negative net margin of 2.31% and a negative return on equity of 9.03%. The business had revenue of $306.12 million for the quarter, compared to analysts’ expectations of $300.51 million. During the same period in the previous year, the company posted ($0.60) earnings per share. The business’s revenue for the quarter was up 19.4% compared to the same quarter last year. Equities research analysts predict that Trupanion will post -0.43 EPS for the current fiscal year.

Institutional Investors Weigh In On Trupanion

A number of institutional investors have recently modified their holdings of TRUP. Wellington Management Group LLP boosted its stake in Trupanion by 34.6% in the fourth quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock valued at $74,862,000 after acquiring an additional 630,155 shares during the period. Sivia Capital Partners LLC bought a new stake in shares of Trupanion in the 4th quarter worth approximately $31,398,000. 8 Knots Management LLC acquired a new position in Trupanion during the 4th quarter valued at approximately $21,165,000. Charles Schwab Investment Management Inc. grew its stake in Trupanion by 2.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 300,029 shares of the financial services provider’s stock worth $9,154,000 after buying an additional 7,088 shares during the last quarter. Finally, Lagoda Investment Management L.P. lifted its stake in Trupanion by 19.3% in the third quarter. Lagoda Investment Management L.P. now owns 240,785 shares of the financial services provider’s stock valued at $6,790,000 after buying an additional 38,905 shares during the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Articles

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.